Skip to content

Comparison of the application effect of remifentanil besylate and propofol in anesthesia of painless abortion patients

Comparison of the application effect of remifentanil besylate and propofol in anesthesia of painless abortion patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090237
Enrollment
Unknown
Registered
2024-09-26
Start date
2024-09-30
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

painless abortion

Interventions

Rimazolen benzenesulfonate (R group):Rimazolen benzenesulfonate
Propofol (P group):Propofol

Sponsors

Deyang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1) Patients planning to undergo elective painless abortion; 2) Age 18-50 years old, female; 3) Body Mass Index (BMI): 18.5-28 kg/m2; 4) American Society of Anesthesiologists (ASA) classification: I-II; 5) Voluntarily participate in the experiment and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Individuals with a history of allergies to opioid drugs, benzodiazepines, propofol, flumazenil, or naloxone excipients; 2) Use beta blockers, anti anxiety drugs, and antidepressants; 3) Suspected abusers of narcotic analgesics or sedatives, as well as alcoholics; 4) Electrocardiogram prompt: heart rate100 beats/min or severe arrhythmia; 5) History of acute respiratory infection within 2 weeks without cure; 6) Individuals with a history of severe heart, brain, lung, liver, kidney, or metabolic diseases, as well as those with neurological and muscular disorders (such as myasthenia gravis) or mental illnesses; 7) Preoperative hypertension patients with systolic blood pressure>180 mmHg and/or diastolic blood pressure>110 mmHg, or hypotension patients<90/60 mmHg; 8) Individuals with a history of abnormal recovery from surgical anesthesia (delayed awakening, malignant hyperthermia); 9) Predict the possibility or occurrence of difficult airways, or improve the Mahalanobis classification III-IV level; 10) Other researchers believe that other subjects who are not suitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
The incidence of hypotension;

Secondary

MeasureTime frame
Proportion of successful operations;The occurrence of respiratory depression;Time indicator;body movement;Total dosage of medication;Number and dosage of intraoperative medication additions;Postoperative nausea and vomiting;

Countries

China

Contacts

Public ContactXia Leqiang

Deyang People's Hospital

649385448@qq.com+86 135 4709 8458

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026